BAX:NYE-Baxter International Inc.

EQUITY | Medical Instruments & Equipment | New York Stock Exchange

Last Closing

USD 76.95

Change

+0.01 (+0.01)%

Market Cap

USD 25.26B

Volume

1.86M

Analyst Target

USD 79.59
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Baxter International Inc is a healthcare company. It develops, manufactures and markets products that save and sustain the lives of people with immune disorders, infectious diseases, kidney disease, trauma and other chronic conditions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-03-18 )

Largest Industry Peers for Medical Instruments & Equipment

ETFs Containing BAX

PBI Pitney Bowes Inc 0.00 % 0.79 %

+0.14 (+3.30%)

USD 0.74B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Equipment) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.91% 86% B+ 73% C
Dividend Return 0.29% 56% F 10% F
Total Return 17.20% 86% B+ 72% C
Trailing 12 Months  
Capital Gain 13.35% 46% F 87% B+
Dividend Return 1.12% 60% D- 18% F
Total Return 14.46% 54% F 85% B
Trailing 5 Years  
Capital Gain 14.32% 10% F 63% D
Dividend Return 54.68% 100% F 99% N/A
Total Return 69.00% 10% F 84% B
Average Annual (5 Year Horizon)  
Capital Gain 5.29% 15% F 68% D+
Dividend Return 18.03% 38% F 89% A-
Total Return 12.74% 100% F 99% N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.21% 54% F 46% F
Risk Adjusted Return 111.29% 54% F 90% A-
Market Capitalization 25.26B 92% A 95% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Instruments & Equipment) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 5.30 92% 24%
Price/Book Ratio 4.48 62% 16%
Price / Cash Flow Ratio 5.17 85% 21%
Price/Free Cash Flow Ratio 28.61 85% 17%
Management Effectiveness  
Return on Equity 18.61% 85% 80%
Return on Invested Capital 13.08% 69% 68%
Return on Assets 9.85% 77% 87%
Debt to Equity Ratio 40.25% 58% 70%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.